Mobility challenges and solutions for fibrodysplasia ossificans progressiva

Archives of Physical Medicine and Rehabilitation

Volumn 80, Issue 10, 1999, Pages 1349-1353

  Levy, Charles ^a,c   Berner, Theresa F ^a   Sandhu, Paul S ^a   McCarty, Beth ^b   Denniston, Nancy L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b Schwab Rehabilitation Hospital   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; FEMALE; HUMAN; JOB PERFORMANCE; JOINT MOBILITY; OSSIFYING MYOSITIS; SHOE; WALKING; WHEELCHAIR;

EID: 13044276238     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(99)90043-6     Document Type: Article

References (13)

1. Connor JM, Skirtin H, Lunt PW. A three generation family with fibrodysplasia ossificans progressiva. J Med Genet 1993;30:687-9.
2. Kaplan FS, McCluskey W, Hahn G, Tabas JA, Muenke M, Zasloff M. Genetic transmission of fibrodysplasia ossificans progressiva. J Bone Joint Surg 1993;75:1214-20.
3. Connor JM, Evans DAP. Genetic aspects of fibrodysplasia ossificans progressiva. J Med Genet 1982;19:35-9.
4. Thornton YS, Birnbaum SJ, Liebowitz N. A viable pregnancy in a patient with myositis ossificans progressiva. Am J Obstet Gynecol 1987;156:577-8.
5. Whyte MP, Kaplan FS, Shore E. Fibrodysplia ossificans progressiva. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 3rd ed. Philadelphia (PA): Lippincott-Raven; 1996. p. 428-30.
6. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub RT, Muenke M, et al. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 1996;335:555-61.
7. Connor JM. Fibrodysplasia ossificans progressiva. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley-Liss, Inc.; 1993, p. 603-11.
8. Heighten P. Fibrodysplasia ossificans progressiva. In Beighton P, editor. Heritable disorders of connective tissues. St. Louis (MO): Mosby; 1993. p. 501-18.
9. Rocke DM, Zasloff M, Peeper J, Cohen RB, Kaplan FS. Age and joint-specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. Clin Orthop 1994;301:243-8.
10. Wieder DL. Treatment of traumatic myositis ossificans with acetic acid iontophoresis. Phys Ther 1992;72:133-6.
11. Kussmaul WG, Esmail AN, Sagar Y, Ross J, Gregory S, Kaplan FS. Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva. Clin Orthop 1998;346:104-9.
12. Sarnow MR, Veves A, Giurini JM, Rosenblum BI, Chrzan JS, Habershaw GM. In-shoe foot pressure measurements in diabetic patients with at-risk feet and in healthy subjects. Diabetes Care 1994;17:1002-6.
13. Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996;13:979-82.